Quince Therapeutics, Inc.QNCXNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-38.98M
↓ 16% vs avg
Percentile
P38
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
$-33.65M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-38.98M | -21.2% |
| 2024 | $-32.16M | -74.3% |
| 2023 | $-18.45M | +58.2% |
| 2022 | $-44.17M | +30.0% |
| 2021 | $-63.11M | -24.1% |
| 2020 | $-50.87M | -52.6% |
| 2019 | $-33.33M | -179.9% |
| 2018 | $-11.91M | -20.2% |
| 2017 | $-9.90M | - |